Predominance of large low density lipoprotein particles and lower fractional esterification rate of cholesterol in high density lipoprotein in children with insulin-dependent diabetes mellitus

European Journal of Pediatrics

Volumn 157, Issue 4, 1998, Pages 276-281

  Ohta, T ^a   Nishiyama, S ^a   Nakamura, T ^a   Saku, K ^b   Maung, K K ^a   Matsuda, I ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Children with IDDM; Coronary artery diseases; FER(HDL); LDL size

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; ESTERIFICATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL;

ADOLESCENT; CHILD; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ESTERIFICATION; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; PARTICLE SIZE; RISK FACTORS; TRIGLYCERIDES; ULTRACENTRIFUGATION;

EID: 0031956492     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050810     Document Type: Article

References (47)

1. Arad Y, Ramakrishnan R, Ginsberg HN (1990) Lovastatin therapy reduces low density lipoprotein apoB level in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. J Lipid Res 31:567-582
2. Arad Y, Rumsey SC, Galeano NF, Al-Haideri M, Walsh MT, Marcel YL, Milne RW, Kwiterovich PO, Deckelbaum RJ (1992) LDL has optimal size for maximal binding to the LDL receptor. Circulation 86:1-551
3. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM (1988) Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921
4. Barakat HA, Carpenter JW, McLendon VD (1990) Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Diabetes 39:1527-1533
5. Barter PJ, Hopkins GJ, Gorjatschko L, Jones ME (1984) Competitive inhibition of plasma cholesterol esterification by human high density lipoprotein subfraction 2. Biochim Biophys Acta 793:260-268
6. Barter PJ, Hopkings GJ, Gorjatschko L (1985) Lipoprotein substrates for plasma cholesterol esteritication. Influence of particle size and composition of the high density lipoprotein subfraction 3, Atherosclerosis 58:97-107
7. Brunzell JD, Porte D Jr, Bierman EL (1975) Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes). Metabolism 24:1123-1137
8. Burstein M, Scholnick HR, Morfin R (1970) Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11:583-595
9. Calvert GD, Graham JJ, Mannik T, Wise PH, Yeates EA (1978) Effects of therapy on plasma high density lipoprotein cholesterol concentration in diabetes mellitus. Lancet 11:66-68
10. Campos H, Genest Jr JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ (1992) Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12:187-195
11. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Heart Study. JAMA 256:2835-2838
12. Coresh J, Kwiterovich Jr PO, Smith HH, Bachorik PS (1993) Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 34:1687-1697
13. Crouse JR, Parks JS, Schey HM, Kahl FR (1985) Studies of low-density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 26:566-574
14. De Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF (1991) Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11:298-306
15. Dejager S, Bruckert E, Chapman MJ (1993) Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res 34:295-308
16. Dobiasova, Stribrna J, Sparks DL, Pritchard PH, Frohlich JJ (1991) Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease. Arterioscler Thromb 11:64-70
17. Dobiasova M, Frohlich JJ (1994) Structural and functional assessment of HDL heterogeneity. Clin Chem 40:1554-1558
18. Dobiasova M (1983) Lecithin cholesterol acyltransferase and the regulation of endogenous cholesterol transport. Adv Lipid Res 20:107-194
19. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RG (1984) Abnormalities in very low, low, and high density lipoproteins and hypertriglyceridemia. Reverse toward normal with bezafibrate treatment. J Clin Invest 74:470-482
20. Garg A (1994) Management of dyslipidemia in IDDM patients. Diabetes Care 17:224-234
21. Genest Jr JJ, McNamara JR, Salem DN, Schaefer EJ (1991) Prevalence of risk factors in men with premature coronary artery disease. Am J Cardiol 67:1185-1189
22. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62:707-714
23. Grundy SM, Chait A, Brunzell JD (1989) Familial combined hyperlipidemia workshop. Arteriosclerosis 7:203-207
24. Hamsten A, Walldius G, Szamosi A, Dahlen G, Faire U de (1986) Relationship of angiographically defined coronary artery-disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation 73:1097-1110
25. Ikeda Y, Ohta T, Matsuda I (1994) Interaction between apoA-I-containing lipoproteins and lecithin: cholesterol acyltransferase. Biochim Biophys Acta 1215:307-313
26. Kannel WB, Castelli WP, Goldon T, McNamara PM (1971) Serum cholesterol, lipoproteins and the risk of coronary heart disease. Ann Intern Med 74:1-12
27. Kessler I (1971) Mortality experience of diabetic patients. A twenty-six year follow-up study. Am J Med 51:715-724
28. Lopes-Virella MFL, Stone PG, Colwell JA (1977) Serum high density lipoproteins in diabetic patients. Diabetologia 13:285-291
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275
30. Marks HH, Krall LF (1971) Onset, course, prognosis and mortality in diabetes mellitus. In: Marble A, White P, Bradley RF, Krall LF (eds), Joslin's diabetes mellitus. Lea and Febiger, Philadelphia, pp 209-254
31. Marietta AD, Foster DM, Brunzell JD (1990) Conversion of plasma VLDL and IDL precursors into various LDL subpopulations using density gradient ultracentrifueation. J Lipid Res 31:975-984
32. Miller GJ, Miller NE (1975) Plasma high density lipoprotein concentration and development of ischemic heart disease. Lancet 1:16-19
33. Murakami T, Michelangnoli S, Longhi R, Gianfranceschi G, Pazzucconi F, Calabresi L, Sirtori CR, Franceschini G (1995) Triglyceride are major determinants of cholesterol esterification transfer and HDL remodeling in human plasma. Arterioscler Thromb Vase Biol 15:1819-1828
34. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057
35. Nichols AV, Krauss RM, Lindgren FT, Forte TM (1986) Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 128:417-431
36. Nieminen MS, Mattila KJ, Aalto-Setala K, Kuusi T, Kontula K, Kauppinen-Makelin R, Ehnholm C, jauhiainen M, Valle M, Taskinen MR (1992) Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler Thromb 12:58-69
37. Norum KR, Gjone E, Glomset JA (1989) Familial lecithin: cholesterol acyltransferase deficiency including fish eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1181-1194
38. Ohta T, Nakamura R, Nishiyama S, Kodama M, Matsuda I (1990) Lipid and apolipoprotein compositions of two species of apoA-I containing lipoproteins in young girls with insulin-dependent diabetes mellitus. Pediatr Res 28:42-15
39. Ohta T, Saku K, Takata K, Nakamura R, Ikeda Y, Matsuda I (1995) Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterificalion in plasma and net cholesterol efflux from foam cells. Arterioscler Thromb Vase Biol 15:956-962
40. Ohta T, Kakiuti Y, Kurahara K, Saku K, Nagata N, Matsuda I (1997) Fractional esterification rate of cholesterol in high density lipoprotein is correlated with low density lipoprotein particle size in children. J Lipid Res 38:139-146
41. O'Looney PA, Vahouny GV (1987) Diabetes and lipoprotein lipase activity. In: Borensztajn J (ed). Lipoprotein lipase. Evener, Chicago, pp 229-246
42. Rader DJ, Ikewaki K, Duverger N, Feuerstein I, Zech L, Conner W, Brewer Jr HB (1993) Very low high-density lipoproteins without coronary atherosclerosis. Lancet 342:1455-1458
43. Reckless JPD, Betteridge DJ, Wu P, Payne B, Galton DJ (1978) High density and low density lipoprotein and prevalence of vascular disease in diabetes mellitus. BMJ 1:883-886
44. Schaefer EJ, Zech LA, Schwartz DE, Brewer Jr HB (1980) Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann Intern Med 93:261-266
45. Tribble DL, Holl LG, Wood PD, Krauss RM (1992) Variations in oxidative susceptibility among six low density subfractions of differing density and particle size. Arteriosclerosis 93:189-199
46. Warnick GR, Nguyen T, Albers AA (1985) Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol. Clin Chem 31:217-222
47. Williams PT, Karen KM, Krauss RM (1992) Correlations of plasma lipoproteins with LDL subfractions by particle size in men and women. J Lipid Res 33:765-774